drugset / Trial / NCT07281274
ADO-5030 in Bronchoconstriction Challenge, Phase 1b
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1 study to learn about the safety and pharmacokinetics of the study drug in patients with asthma and whether the study drug has effect during a respiratory challenge.
Timeline
- Start
- 2026-01-01
- Primary completion
- 2026-06-01
- Completion
- 2026-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ADO-5030 | Unknown | — | Oral |